• general@orthocell.com
  • +61 8 9360 2888
Orthocell Americas
  • Home
  • About
  • Team
  • Products
  • Invest
  • News
  • Practitioners
    • Striate+
    • Remplirâ„¢
    • OrthoACIâ„¢
    • Tendon
  • Contact
  • Region
    • Visit AU – Home
    • Visit Americas
    • Visit EU/UK
  • Home
  • About
  • Team
  • Products
  • Invest
  • News
  • Practitioners
    • Striate+
    • Remplirâ„¢
    • OrthoACIâ„¢
    • Tendon
  • Contact
  • Region
    • Visit AU – Home
    • Visit Americas
    • Visit EU/UK
26 May 2021
Orthocell Media Permalink

Orthocell (ASX:OCC) granted new patents for ACL repair treatment

Orthocell 26 May 2021

Orthocell has been featured in The Market Herald, following our announcement of granted patents in China and Hong Kong for its novel CelGro collagen rope device for ACL repairs.

Read more

15 Feb 2021
Orthocell Media Permalink

Orthocell (ASX:OCC) receives new U.S. patent for CelGro

Orthocell 15 February 2021

Orthocell has been featured in The Market Herald, following the announcement of a newly granted U.S. divisional patent for CelGro.

Read the article HERE.

14 Jan 2021
Orthocell Media Permalink

Orthocell’s stock soars following FDA 510(k) clearance of regenerative collagen medical device

Orthocell 14 January 2021

BioWorld has reported on Orthocell’s rising share price, following the U.S. approval for our collagen medical device for dental guided bone and soft tissue regeneration applications.

Read more

09 Jan 2021
Orthocell Media Permalink

UWA invention to speed up healing in dental patients

Orthocell 9 January 2021

Orthocell’s Striate+â„¢ has been featured in Bite Magazine, highlighting its effectiveness for dental bone defect repair and tissue augmentation around dental implants.

Read more

06 Jan 2021
Orthocell Video Permalink

Australia’s TGA approves Orthocell’s Celgro™ regenerative collagen medical device

Orthocell 6 January 2021

Orthocell CEO Paul Anderson spoke to BioWorld, following marketing clearance from Australia’s Therapeutic Goods Administration (TGA) for our Celgro™ collagen medical device for dental guided bone and soft tissue regeneration applications. 

Read more

20 Nov 2020
Orthocell Media Permalink

Medical miracle brings limbs back to life

Orthocell 20 November 2020

The incredible story of Adrian Walsh, featuring Orthocell’s CelGroâ„¢ nerve treatment, has been featured in the Weekend Australian.

Read more

10 Nov 2020
Orthocell Video Permalink

HCP Webinar | Latest Developments in the Biological Treatment of Cartilage – Professor Martin Sullivan

Orthocell 10 November 2020

Professor Martin Sullivan Foot and Ankle Surgeon at St. Vincent’s Clinic & North Shore Private Hospital in Sydney presents ‘An Australian Perspective on the Management of Large Cartilage Defects in the Ankle Over 25 Years’

Read more

22 Sep 2020
Orthocell Media, Video Permalink

Video | Proactive Investors Interview – September 2020

Orthocell 22 September 2020

Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about the company being in an exciting regulatory phase, having validated its technologies in the clinic and defining pathways to market through the US FDA process.

Read more

22 May 2020
Orthocell Video Permalink

Australia’s Orthocell submits 510(k) for Celgro™ regenerative collagen medical device

Orthocell 22 May 2020

Orthocell has been featured in BioWorld, following the submission of a 510(k) application to the U.S. FDA for our Celgroâ„¢ collagen medical device for dental guided bone and soft tissue regeneration applications.

Read more

11 Mar 2020
Orthocell Video Permalink

Orthocell looks to enter US market following positive CelGroâ„¢ study results

Orthocell 11 March 2020

Small Caps has featured Orthocell’s plans to enter the US market following the success of our Celgroâ„¢ dental implant study. 

Read more

  • Recent posts

    • First US Surgical Use of Remplir™ 
    • Breakthrough Study Confirms Remplirâ„¢ Superiority Over Standard US Nerve Repair Technique
    • Stockhead | Interview with Dr Ian Valerio
    • The West Australian | Biotech’s easy cell to crack American market
    • Orthocell Receives Regulatory Approval for Remplirâ„¢ in Hong Kong
Previous
Next
  • © Orthocell Ltd. All rights reserved.

  • Contact Us

  • P: +61 8 9360 2888
    F: +61 8 9360 2899
    E: general@orthocell.com

  • News Updates

  • By entering your email address you are agreeing to our privacy policy.

BUILT WITH ♡ BY H^CK Orthocell Americas POWERED BY United Themes™
Please select the country you would like to view

Visit AU – Home

Visit Americas

Visit EU/UK

Join our mailing list

    By entering your email address you are agreeing to our privacy policy.


    Sign up to our EDM

    By entering your email address you are agreeing to our privacy policy.

    Patient expression of interest